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a b s t r a c t 
The dataset provides information on Pharmaceutical and Per- 
sonal Care Products (PPCPs) detected in the Albufera Natural 
Park (Valencia, Spain), a typical Mediterranean coastal wet- 
land. These PPCPs constitute an important group of organic 
pollutants highly representative of the human impact. 
The concentrations values measured in soil, sediment and 
water and the statistical relationship of contaminants be- 
tween them and with the environmental parameters could 
help to understand their fate in different compartments. The 
data also reported the occurrence and removal efficiency (%) 
for each contaminant in ten wastewater treatment plants 
(WWTPs), located in the surrounding area. This dataset could 
provide an idea on the effectiveness of WWTP treatments 
and the capacity of released PPCPs to affect the ecosystem. 
The extraction of analytes was based on solid-phase extrac- 
tion (SPE) for water and solvent extraction followed by the 
previous SPE as clean-up for soil and sediment. Determi- 
nation was carried out by high performance liquid chro- 
matography tandem mass spectrometry (HPLC-MS/MS) with 
a triple-quadrupole. 
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The present dataset was analyzed within the article enti- 
tled: “Pharmaceuticals and personal care products in a Mediter- 
ranean coastal wetland: Impact of anthropogenic and spatial 
factors and environmental risk assessment” [1] . 
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Specific subject area Pharmaceuticals and personal care products occurrence and fate in 
Mediterranean coastal wetlands. 
Type of data Table 
How data were acquired Raw data were acquired via HPLC-MS/MS. The instrument was an Infinity 1260 
UHPLC system, coupled to mass spectrometry with a triple-quadrupole mass 
detector 6410 (QqQ-MS) from Agilent Technologies (Santa Clara, CA, USA). The 
ionization technique used was electrospray ionization (ESI). 
Data format Raw 
Analyzed 
Filtered 
Parameters for data collection The mobile phase consisted of 2.5 mmol L −1 NH 4 F in methanol (A) and 2.5 
mmol L −1 NH 4 F in water (B) for negative mode and methanol and water with 
0.1% formic acid in both solutions for positive mode. 
The other parameters are described in literature [2] . 
Description of data collection Data were obtained analysing environmental samples (soil, sediment and 
water) collected in 44 sampling points of the Albufera Natural Park and in ten 
wastewater treatment plants (WWTPs), located in the surrounding area. The 
final value concentrations were achieved by HPLC-MS/MS analysis. 
Data source location Institution: University of Valencia, Research Center on Desertification (CIDE) 
City: Valencia 
Country: Spain 
Latitude and longitude (and GPS coordinates, if possible) for collected 
samples/data: All coordinates are specified in related research article [1] . 




41794 4 40579224323&z=11 
Data accessibility Pico, Yolanda; Sadutto, Daniele; Andreu, Vicente; Ilo, Timo; Akkanen, Jarkko 
(2021), “Details on the Dataset of pharmaceuticals and personal care products 
in a Mediterranean coastal wetland”, Mendeley Data, V1, 
http://dx.doi.org/10.17632/zy2zg7dhgv.1 
Related research article Daniele Sadutto, Vicente Andreu, Timo Ilo, Jarkko Akkanen, Yolanda Picó. 
Pharmaceuticals and personal care products in a Mediterranean coastal wetland: 
Impact of anthropogenic and spatial factors and environmental risk assessment , 
Environmental Pollution, 2021, 271: p. 116353. 
https://doi.org/10.1016/j.envpol.2020.116353 
alue of the Data 
• The contaminants monitoring of a Natural Park (Albufera) is needed to value the environ-
mental risk and how it is related with anthropogenic pressures. In addition, statistical corre-
lations show a relationship between studied PPCPs and the different matrices. 
• National and international authorities, wastewater treatment plant managers and researchers
can estimate removal, occurrence, transport and fate of PPCPs. 
• The data of PPCPs occurrence in sediment, soil and water samples could serve as a knowledge
base that allows the establishment of monitoring programs for the compounds that appear











































with a higher frequency and establish a better assessment of the risks that exist for this
natural space. 
• The concentrations on each sampling point may help to understand the geophysical distribu-
tion of these contaminants and can be compared with other studies. 
1. Data Description 
The presented data were collected in the Albufera Natural Park (Valencia, Spain), which is
included in the list of international wetlands (RAMSAR) (since 1990), in the Natura 20 0 0 net-
work as a Special Protection Area for Birds (SPA) under the Birds Directive, and is considered a
Site of Community Importance (SCI) under Habitats Directive. This area of about 210 0 0 hectares
(ha) included a coastal lagoon fed by streams, rivers and irrigation channels, a sandy shoreline
belt, rice paddies, vegetables and orange orchards in its most external part, where 43 sampling
points and ten wastewater treatment plants (WWTPs), that discharged into irrigation channels
that eventually end up in the park, were monitored. Strong anthropic pressure has already been
noted in the area due to the proximity of Valencia city and its metropolitan area [3] . The occur-
rence of 32 pharmaceutical and personal care products (PPCPs) was investigated from November
2016 to February 2017. Detailed information of each sampling site is provided in the related ar-
ticle. Tables 1 –2 shows the concentration of PPCPs in influent (i) and effluent (e) wastewater
samples with relative date of collection. While, the removal efficiency (%) for each compound
was reported in Table 3 . The occurrence of (32) water, (19) sediment and (33) soil samples was
described in Tables 4 –6 . The data presented in Tables 1–2 and 4 –6 are the average value of three
method’s replicates for each sample to check reproducibility. In the public repository (Mendeley
Data) [4] have been published the additional tables (named table S. “n °”), that contain the re-
sults of each individual extraction as well as the average (Tables S1-S5) and the linearity (R 2 ),
LOD, LOQ and matrix effect (ME) for each contaminant (Table S6-S7). The Statistical correlations
between the studied PPCPs in soils, sediment and water were described in Tables 7 –9 . At last,
statistical correlations between contaminants and intrinsic characteristics of all matrices were
schematized in Tables 10 –12 . The intrinsic characteristics considered were temperature, pH, to-
tal soluble salts, dissolved O 2 and redox potential in water, organic matter, carbonates, lime,
clay and sand, pH, electric conductivity and cationic exchange capacity in sediments and organic
matter, carbonates, sodium, potassium, magnesium and calcium, pH, electric conductivity and
cationic exchange capacity in soil. 
2. Experimental Design, Materials and Methods 
The water characteristics were in situ measured using a portable Multiparameter Eutech In-
strument CyberScan PCD 650 (Thermo Fisher Scientific, Basel, Switzerland). The soil and sed-
iment characteristics were established in the laboratory using standard procedures. Organic
matter was determined by oxidation with dichromate [5] . Carbonate was determined using
the Bernard calcimeter [6] method and cationic exchanger capacity was calculated measuring
sodium, potassium, magnesium and calcium by extraction with 1 M ammonium acetate solution
and inductively coupled plasma optical emission spectroscopy) (ICP-OES) following the method
of Rhoades [7] . Electric conductivity and pH were determined in the soil saturation extract with
a pH-meter according to Richards [8] and finally, % of lime, clay and sand were established
using an hydrometer according to the Bouyoucos [9] method. The waste and surface waters
(200 mL) were vacuum filtered by a 0.6-μm glass fiber filter (GA-55, 90 mm - Advantec MFS,
Dublin, CA, USA) and stored at -20 °C until the analysis. The sediments were lyophilized with
a Virtis lyophilizer (SP Scientific, Gardiner, NY, USA) and the soil samples were sieved, and
air-dried in the dark at 20 °C to reduce the moisture content. The samples of water, soil and













































Concentration of PPCPs (ng L −1 ) in the influents (i) of the WWTPs ∗ . 
Compound 
iAS iCAT iCAT iPAL iSAL iPE iPI iPI iPII iPII iPS iQB iSU 
25/11/2016 22/11/2016 13/01/2017 14/12/2016 13/01/2017 13/01/2017 22/11/2016 13/01/2017 22/11/2016 13/01/2017 25/11/2016 14/12/2016 25/11/2016 
Alprazolam 2.30 n.d. ∗∗ 2.42 4.03 1.43 3.01 3.82 4.34 4.23 4.01 2.33 7.12 1.91 
Atenolol 132 5.63 63.5 113 22.9 162 236 335 154 244 82.0 257 174 
Atorvastatine 83.1 2.65 134 157 27.2 59.7 148 278 166 231 63.0 274 61.0 
Bezafibrate 5.22 0.91 52.3 1.62 1.21 3.02 29.5 35.0 26.3 21.0 0.32 31.0 3.12 
BPA 562 37.1 4.27 × 10 3 147 66.2 87.9 166 238 400 387 110 1.01 × 10 3 92.0 
Butylparaben 5.43 n.d. 18.4 19.2 1.82 n.d. 13.6 33.0 1.92 10.8 9.14 4.62 6.73 
Caffeine 8.70 × 10 3 9.78 × 10 3 9.36 × 10 3 6.08 × 10 3 2.46 × 10 3 5.24 × 10 3 9.99 × 10 3 1.32 × 10 3 6.95 × 10 3 8.36 × 10 3 4.34 × 10 3 18.07 × 10 3 4.3 × 10 3 
Chloramphenicol 2.01 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.41 
Clofibric acid n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Codeine 68.4 1.12 52.2 7.01 10.0 50.2 52.1 133 80.9 93.8 47.5 71.8 72.0 
Diclofenac 324 n.d. 290 303 68.0 123 324 380 386 320 327 348 275 
Enelapril 379 n.d. 283 63.8 n.d. n.d. 288 281 243 141 119 510 127 
Ethylparaben 25.0 4.34 174 87.2 5.32 3.03 87.2 43.0 0.52 1.71 5.21 43.0 73.0 
Etoricoxib 9.31 1.32 17.4 14.8 6.03 6.94 14.9 15.0 18.5 22.0 12.0 36.1 7.42 
Flufenamic acid 126 0.84 78.0 75.2 26.4 86.7 136 175 178 205 48.9 415 95.3 
Furosemide 411 n.d. 354 198 n.d. 268 4 4 4 700 557 598 266 927 310 
Ibuprofen 11.0 × 10 3 2.32 × 10 3 12.60 × 10 3 6.51 × 10 3 2.57 × 10 3 6.99 × 10 3 7.97 × 10 3 1.42 × 10 3 7.79 × 10 3 10.3 × 10 3 5.58 × 10 3 11.5 × 10 3 57.6 × 10 3 
Indomethacin 6.03 n.d. 0.62 n.d. 1.03 n.d. 4.52 7.32 n.d. 3.82 n.d. n.d. 0.72 
Lorazepam 30.6 33.0 26.0 18.1 17.0 29.4 30.2 51.0 43.1 35.3 13.7 92.0 30.0 
Metformin 190 3.62 338 323 47.9 286 256 410 260 321 206 319 135 
Methylparaben 354 24.2 388 625 59.0 132 286 1.28 × 10 3 36.5 24.8 164 115 610 
Naproxen 2.56 × 10 3 50.4 3.58 × 10 3 632 570 1.84 × 10 3 2.85 × 10 3 3.38 × 10 3 2.55 × 10 3 2.85 × 10 3 2.10 × 10 3 3.02 × 10 3 2.00 × 10 3 
Omeprazole n.d. n.d. 1.0 n.d. n.d. n.d. n.d. 270 n.d. n.d. n.d. n.d. 158 
Paracetamol 2.83 × 10 3 4.94 × 10 3 5.92 × 10 3 6.08 × 10 3 3.15 × 10 3 4.52 × 10 3 4.34 × 10 3 6.78 × 10 3 1.86 × 10 3 3.81 × 10 3 5.50 × 10 3 4.50 × 10 3 5.35 × 10 3 
Propylparaben 188 11.7 395 288 39.9 319 373 627 111 224 290 134 275 
Salicylic acid 779 167 2.01 × 10 3 1.61 × 10 3 250 394 1.41 × 10 3 2.58 × 10 3 237 187 730 1.49 × 10 3 1.76 × 10 3 
Simvastatin 2.06 × 10 3 n.d. 1.67 × 10 3 1.30 × 10 3 186 606 1.28 × 10 3 2.02 × 10 3 1.31 × 10 3 2.03 × 10 3 1.60 × 10 3 2.05 × 10 3 1.75 × 10 3 
Thiamphenicol n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Tramadol 569 153 551 297 138 419 587 859 681 750 220 1.05 × 10 3 416 
Triclocarban 0.74 0.42 n.d. 0.41 n.d. 0.53 1.72 1.51 1.12 0.63 0.91 0.82 0.71 
Triclosan 102 40.4 99.5 77.0 50.0 n.d. 308 410 56.2 133 156 153 104 
Warfarin n.d. n.d. 0.33 0.54 n.d. 0.45 n.d. n.d. 1.15 n.d. n.d. 0.21 n.d. 
∗ WWTPs: Pinedo 1 (PI), Pinedo 2 (PII), Port de Catarroja (CAT), Quart - Benàger (QB), Sueca (SU), Perelló-Sueca (PS), Perellonet (PE), Palmar (PAL), Saler (SAL) and Albufera Sud (AS) 













































Concentration of PPCPs (ng L −1 ) in the effluents (e) of the WWTPs ∗ . 
Compound 
eAS eCAT eCAT ePAL eSAL ePE ePI ePI ePII ePII ePS eQB eSU 
25/11/2016 22/11/2016 13/01/2017 14/12/2016 13/01/2017 13/01/2017 22/11/2016 13/01/2017 22/11/2016 13/01/2017 25/11/2016 14/12/2016 25/11/2016 
Alprazolam 3.20 n.d. ∗∗ n.d. 5.90 1.60 2.30 7.50 5.10 9.00 7.00 2.90 7.70 4.60 
Atenolol 14.0 8.40 140 26.0 19.0 4.00 148 190 125 137 11.7 104 24.4 
Atorvastatine n.d. n.d. n.d. n.d. n.d. n.d. 152 143 52.9 146 n.d. 19.0 15.7 
Bezafibrate 1.80 0.50 0.30 0.40 2.00 1.00 29.6 35.1 6.90 20.4 0.50 20.4 12.3 
BPA 93.0 19.0 n.d. 35.8 11.0 41.0 181 165 65.3 240 71.0 221 83.0 
Butylparaben 0.40 n.d. n.d. n.d. n.d. n.d. 0.20 0.20 n.d. 1.50 n.d. n.d. n.d. 
Caffeine 8.80 5.50 43.0 149 28.9 36.0 15.3 72.0 40.4 151 26.8 455 40.0 
Chloramphenicol n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Clofibric acid n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Codeine 14.1 1.40 0.20 7.10 3.50 7.30 50.1 76.1 53.6 96.7 24.5 32.8 31.0 
Diclofenac 164 n.d. n.d. 164 29.0 57.0 711 433 525 490 114 259 199 
Enelapril n.d. n.d. n.d. n.d. n.d. n.d. n.d. 83.0 n.d. n.d. n.d. n.d. n.d. 
Ethylparaben n.d. n.d. 0.20 0.30 0.50 0.40 n.d. 0.50 n.d. 1.00 0.60 4.00 0.30 
Etoricoxib 8.00 2.60 1.40 19.5 3.70 4.70 25.7 24.7 30.2 22.5 13.4 22.1 27.7 
Flufenamic acid 137 0.40 n.d. 95.8 22.0 65.0 350 200 277 200 45.0 328 187 
Furosemide 134 n.d. n.d. n.d. 2.00 30.0 904 550 552 630 66.1 427 313 
Ibuprofen n.d. 499 231 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Indomethacin n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.80 n.d. 7.90 n.d. n.d. n.d. 
Lorazepam 18.1 n.d. n.d. 42.9 8.60 17.0 61.3 54.4 63.1 57.1 28.0 46.6 36.5 
Metformin 6.50 2.00 4.40 9.90 1.10 8.00 66.3 34.9 18.9 24.0 15.6 23.4 26.5 
Methylparaben 20.6 n.d. n.d. 13.6 5.60 4.60 29.1 40.0 20.2 35.0 16.9 30.1 28.7 
Naproxen 23.0 n.d. n.d. 26.3 n.d. n.d. 75.4 n.d. 90.7 146 26.1 318 205 
Omeprazole n.d. n.d. n.d. n.d. n.d. n.d. 30.0 14.0 25.6 23.0 4.00 16.0 n.d. 
Paracetamol 11.3 2.00 19.0 34.8 49.0 39.0 18.1 37.0 16.6 15.4 24.1 37.0 70.0 
Propylparaben 1.30 n.d. 1.70 5.30 4.10 5.00 5.80 10.0 3.70 8.70 3.00 6.20 2.30 
Salicylic acid 1.40 58.4 108 380 310 248 207 345 205 325 124 580 212 
Simvastatin n.d. 245 80.0 n.d. n.d. n.d. n.d. 35.0 n.d. n.d. n.d. n.d. n.d. 
Thiamphenicol n.d. n.d. n.d. n.d. n.d. n.d. n.d. 9.00 n.d. 14.8 n.d. n.d. n.d. 
Tramadol 470 n.d. 3.50 576 120 467 1.10 × 10 3 994 1.28 × 10 3 1.30 × 10 3 273 11.6 × 10 3 666 
Triclocarban n.d. 0.40 n.d. 0.30 0.10 0.10 0.60 0.50 n.d. 0.4 1.20 0.40 0.50 
Triclosan 24.0 n.d. n.d. 22.6 4.30 n.d. 29.2 20.3 10.4 7.4 n.d. 14.0 26.3 
Warfarin 0.50 n.d. n.d. 0.30 n.d. n.d. n.d. n.d. 0.80 0.7 n.d. 0.10 0.40 
∗∗ WWTPs: Pinedo 1 (PI), Pinedo 2 (PII), Port de Catarroja (CAT), Quart - Benàger (QB), Sueca (SU), Perelló-Sueca (PS), Perellonet (PE), Palmar (PAL), Saler (SAL) and Albufera Sud (AS) 













































Removal efficiency (%) for each PPCPs in each WWTPs: Pinedo 1 (PI), Pinedo 2 (PII), Port de Catarroja (CAT), Quart - Benàger (QB), Sueca (SU), Perelló-Sueca (PS), Perellonet (PE), 
Palmar (PAL), Saler (SAL) and Albufera Sud (AS). 
Compound 
AS CAT CAT PAL EPE PI PI PII PII PS EQB SAL SU 
25/11/2016 22/11/2016 13/01/2017 14/12/2016 13/01/2017 22/11/2016 13/01/2017 22/11/2016 13/01/2017 25/11/2016 14/12/2016 13/01/2017 25/11/2016 
Alprazolam −37 / ∗ 100 −47 22 −99 −18 −115 −75 −26 −9 −12 −146 
Atenolol 89 −51 −120 77 98 37 43 19 44 86 60 17 86 
Atorvastatine 100 100 100 100 100 −3 49 68 37 100 93 100 74 
Bezafibrate 66 51 99 72 66 / / 74 3 −67 34 −57 −291 
BPA 83 49 100 76 53 −9 31 84 38 35 78 83 10 
Butylparaben 93 / 100 100 / 98 99 100 86 100 100 100 100 
Caffeine 100 100 100 98 99 100 99 99 98 99 97 99 99 
Chloramphenicol 100 / / / / / / / / / / / 100 
Clofibric acid / / / / / / / / / / / / / 
Codeine 79 −26 100 −1 85 4 43 34 −3 48 54 65 57 
Diclofenac 49 / 100 46 54 −119 −14 −36 −53 65 26 57 28 
Enelapril 100 / 100 100 / 100 70 100 100 100 100 / 100 
Ethylparaben 100 100 100 100 87 100 99 100 42 89 91 90 100 
Etoricoxib 14 −108 92 −31 32 −72 −65 −63 −2 −12 39 39 −275 
Flufenamic acid −8 48 100 −27 25 −158 −14 −56 2 8 21 17 −96 
Furosemide 67 / 100 100 89 −103 21 1 −5 75 54 ! −1 
Ibuprofen 100 79 98 100 100 100 100 100 100 100 100 100 100 
Indomethacin 100 / 100 / / 100 76 / −108 / / 100 100 
Lorazepam 41 100 100 −137 42 −103 −7 −46 −62 −104 49 49 −22 
Metformin 97 44 99 97 97 74 91 93 93 92 93 98 80 
Methylparaben 94 100 100 98 96 90 97 45 −41 90 74 90 95 
Naproxen 99 100 100 96 100 97 100 96 95 99 89 100 90 
Omeprazole / / 100 / / ! ∗∗ 95 ! ! ! ! / 100 
Paracetamol 100 100 100 99 99 100 99 99 100 100 99 98 99 
Propylparaben 99 100 100 98 98 98 98 97 96 99 95 90 99 
Salicylic acid 82 65 95 76 37 85 87 14 −74 83 61 −24 88 
Simvastatin 100 ! 95 100 100 100 98 100 100 100 100 100 100 
Thiamphenicol / / / / / / ! / ! / / / / 
Tramadol 17 100 99 −94 −11 −89 −16 −88 −74 −24 −10 13 −60 
Triclocarban 100 13 / 29 85 68 67 100 38 −31 49 ! 26 
Triclosan 76 100 100 71 / 91 95 82 94 100 91 91 75 
Warfarin ! / 100 39 100 / / 26 ! / 71 / ! 













































Concentration of PPCPs (ng L −1 ) in water samples (W.n °) of the Albufera Natural Park, Valencia, Spain. 
Compound W.1 W.4 W.5 W.6 W.7 W.10 W.11 W.12 W.14 W.15 W.16 W.17 W.18 W.19 W.20 W.21 W.22 W.23 W.26 W.27 W.29 W.30 W.31 W.32 W.33 W.34 W.36 W.37 W.38 W.39 W.40 W.41 W.42 
Alprazolam 10.0 4.00 n.d. ∗ 6.00 n.d. n.d. n.d. 1.00 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 2.00 n.d. 8.00 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Atenolol 320 114 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 62.0 n.d. n.d. n.d. n.d. n.d. n.d. 78 n.d. n.d. n.d. 92.0 52.0 221 72.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Atorvastatin 1.00 n.d. n.d. 1.00 n.d. n.d. n.d. n.d. 21.0 n.d. n.d. n.d. n.d. 1.00 n.d. n.d. n.d. n.d. n.d. n.d. 2.00 1.00 n.d. 21.0 1.00 21.0 1.00 21.0 n.d. 1.00 21.0 1.00 n.d. 
Bezafibrate 79.0 63.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.00 n.d. 2.00 n.d. n.d. n.d. 9.00 n.d. 75.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Bisphenol A 185 145 150 120 48.0 65.0 75.0 56.0 70.0 25.0 51.0 48.0 72.0 45.0 140 57.0 31.0 12.0 19.0 115 140 190 115 158 60.0 205 197 54.0 150 158 130 81.0 150 
Butylparaben n.d. n.d. 70.0 70.0 45.0 n.d. n.d. n.d. n.d. 40.0 n.d. n.d. 40.0 45.0 n.d. 40.0 n.d. n.d. n.d. 70.0 n.d. n.d. 70.0 n.d. 40.0 n.d. 71.0 n.d. 70.0 70.0 42.0 42.0 n.d. 
Caffeine 152 28.0 62.0 22.0 137 56.0 11.0 14.0 291 76.0 152 21.0 134 101 121 219 40.0 668 20.0 43.0 138 541 103 272 157 66.0 173 93.0 141 127 120 16.0 18.0 
Chloramphenicol n.d. n.d. n.d. 50.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 39.0 40.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 40.0 n.d. 50.0 n.d. n.d. 50.0 n.d. n.d. n.d. 
Clofibric acid 76.0 77.0 76.0 76.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 77.0 n.d. n.d. n.d. n.d. 77.0 76.0 75.0 76.0 76.0 n.d. 75.0 76.0 n.d. 76.0 76.0 75.0 n.d. 80.0 
Codeine 154 27.0 n.d. 26.0 n.d. n.d. n.d. n.d. n.d. n.d. 8.00 n.d. n.d. n.d. 7.00 16.0 n.d. 21.0 n.d. n.d. n.d. 36.0 30.0 84.0 12.0 n.d. 39.0 n.d. n.d. n.d. n.d. n.d. n.d. 
Diclofenac 169 70.0 50.0 115 60.0 52.0 75.0 55.0 n.d. 75.0 90.0 67.0 72.0 63.0 n.d. 75.0 65.0 103 75.0 n.d. 45.0 95.0 65.0 82.0 78.0 66.0 n.d. 104 45.0 35.0 72.0 35.0 30.0 
Enalapril n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.00 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 8.00 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Ethylparaben n.d. n.d. 72.0 73.0 78.0 72.0 n.d. 82.0 n.d. 70.0 n.d. 70.0 70.0 70.0 n.d. n.d. n.d. 77.0 73.0 67.0 n.d. 75.0 66.0 67.0 80.0 79.0 70.0 76.0 65.0 n.d. 75.0 70.0 n.d. 
Etoricoxib 18.0 4.00 3.00 8.00 1.00 n.d. 1.00 1.00 n.d. n.d. 2.00 n.d. n.d. 1.00 2.00 2.00 n.d. 2.00 n.d. 2.00 2.00 5.00 5.00 13.0 n.d. n.d. 6.00 7.00 25.0 20.0 3.00 3.00 5.00 
Flufenamic Acid 195 85.0 60.0 150 n.d. 1.00 n.d. n.d. 1.00 2.00 4.00 2.00 n.d. n.d. 61.0 7.00 1.00 15.0 n.d. n.d. n.d. 80.0 80.0 140 10.0 n.d. n.d. 1.00 n.d. n.d. n.d. n.d. n.d. 
Furosemide n.d. 115 n.d. 74.0 48.0 n.d. n.d. n.d. n.d. 70.0 90.0 n.d. n.d. n.d. n.d. n.d. n.d. 65.0 n.d. n.d. n.d. 95.0 85.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Ibuprofen 90.0 85.0 20.0 35.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 144 60.0 217 n.d. n.d. n.d. 90.0 n.d. n.d. 43.0 n.d. n.d. n.d. 
Indomethacin 56.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 25.0 n.d. n.d. n.d. 24.0 n.d. n.d. n.d. n.d. n.d. n.d. 50.0 n.d. 25.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Lorazepam 88.0 15.0 n.d. 15.0 n.d. n.d. n.d. n.d. n.d. n.d. 18.0 n.d. n.d. n.d. n.d. 6.00 n.d. 31.0 n.d. n.d. n.d. 23.0 12.0 70.0 1.00 n.d. n.d. 2.00 n.d. n.d. n.d. 5.00 n.d. 
Metformin 251 66.0 n.d. 19.0 20.0 4.00 3.00 5.00 23.0 15.0 114 26.0 171 3.00 14.0 55.0 2.00 131 375 24.0 25.0 186 70.0 93.0 57.0 18.0 22.0 33.0 94.0 40.0 40.0 6.00 19.0 
Methylparaben 75.0 75.0 107 73.0 82.0 74.0 75.0 80.0 77.0 75.0 79.0 72.0 75.0 74.0 n.d. 75.0 n.d. 82.0 75.0 n.d. 70.0 84.0 75.0 78.0 75.0 73.0 78.0 76.0 73.0 n.d. 75.0 82.0 74.0 
Naproxen 195 145 n.d. 105 n.d. n.d. n.d. n.d. 115 n.d. n.d. n.d. n.d. n.d. n.d. 117 114 208 111 n.d. n.d. 209 225 178 160 n.d. 86.0 n.d. n.d. n.d. 113 115 n.d. 
Omeprazole n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Paracetamol 26.0 n.d. 5.00 n.d. 32.0 14.0 11.0 17.0 82.0 28.0 18.0 n.d. 32.0 31.0 11.0 40.0 n.d. 168 n.d. 25.0 33.0 75.0 17.0 37.0 49.0 43.0 47.0 23.0 23.0 25.0 15.0 23.0 26.0 
Propylparaben n.d. 88.0 75.0 n.d. 38.0 33.0 32.0 35.0 33.0 32.0 30.0 30.0 30.0 30.0 75.0 35.0 30.0 33.0 30.0 90.0 75.0 75.0 75.0 135 31.0 n.d. 75.0 31.0 75.0 70.0 32.0 n.d. 90.0 
Salicylic Acid 99.0 88.0 75.0 113 690 602 n.d. n.d. 840 282 249 n.d. 298 391 294 239 208 751 340 106 521 713 75.0 161 230 686 166 592 240 858 386 301 204 
Simvastatin n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Thiamphenicol 35.0 n.d. n.d. n.d. n.d. 5.00 n.d. 1.00 n.d. n.d. 5.00 n.d. n.d. n.d. n.d. n.d. n.d. 5.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 5.00 35.0 
Tramadol 12.6 × 10 2 197 1.00 523 n.d. 11.0 13.0 12.0 3.00 5.00 18.0 9.00 33.0 7.00 7.0 84.0 n.d. 106 n.d. 22.0 27.0 333 171 695 89.0 3.00 50.0 24.0 56.0 42.0 18.0 n.d. 5.00 
Triclocarban n.d. 15.0 13.0 n.d. n.d. 2.00 n.d. 1.00 1.00 1.00 1.00 1.00 1.00 n.d. n.d. 5.00 n.d. 1.00 n.d. 14.0 n.d. 1.00 13.0 n.d. n.d. n.d. n.d. 1.00 13.0 13.0 15.0 1.00 15.0 
Triclosan 65.0 28.0 n.d. n.d. n.d. n.d. 44.0 50.0 60.0 65.0 n.d. 51.0 55.0 48.0 15.0 72.0 n.d. 52.0 44.0 n.d. 25.0 n.d. 52.0 56.0 50.0 48.0 50.0 n.d. 45.0 31.0 35.0 65.0 20.0 
Warfarin 65.0 65.0 65.0 64.0 n.d. 45.0 n.d. n.d. n.d. n.d. 45.0 n.d. 48.0 n.d. 65.0 45.0 n.d. n.d. 45.0 n.d. n.d. 65.0 70.0 70.0 45.0 65.0 n.d. 46.0 65.0 65.0 n.d. 46.0 n.d. 













































Concentration of PPCPs (ng g −1 ) in sediment samples (S.n °) of the Albufera Natural Park, Valencia, Spain. 
Compound S.5 S.9 S.10 S.15 S.16 S.17 S.18 S.23 S.26 S.30 S.33 S.34 S.35 S.36 S.37 S.38 S.39 S.40 S.41 
Alprazolam n.d. ∗ n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Atenolol n.d. 3.0 n.d. n.d. 2.0 5.0 4.0 4.0 3.0 5.0 5.0 3.0 1.0 n.d. 1.0 4.0 n.d. n.d. 16 
Atorvastatin n.d. n.d. n.d. n.d. n.d. n.d. n.d. 2.0 1.0 n.d. 21 1.0 21 n.d. 1.0 21 n.d. 1.0 21 
Bezafibrate n.d. n.d. n.d. 3.0 n.d. n.d. 3.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 3.0 3.0 n.d. 
Bisphenol A n.d. 15 20 5.0 14 7.0 10 21 7.0 20 18 20 2.0 n.d. 9.0 14 19 19 n.d. 
Butylparaben 6.0 6.0 n.d. 6.0 7.0 n.d. 6.0 n.d. n.d. 6.0 6.0 n.d. 6.0 n.d. 6.0 6.0 6.0 6.0 n.d. 
Caffeine 6.0 9.0 8.0 10 7.0 5.0 8.0 8.0 6.0 7.0 6.0 9.0 6.0 4.0 5.0 4.0 6.0 10 7.0 
Chloramphenicol n.d. 4.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Clofibric acid n.d. 5.0 n.d. n.d. n.d. n.d. 5.0 5.0 5.0 n.d. 4.0 5.0 4.0 4.0 5.0 4.0 5.0 5.0 5.0 
Codeine n.d. 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Diclofenac 3.0 3.0 8.0 8.0 10 6.0 7.0 5.0 n.d. 3.0 6.0 6.0 6.0 n.d. 5.0 3.0 8.0 4.0 4.0 
Enalapril n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Ethylparaben n.d. 17 15 n.d. 16 n.d. n.d. 15 15 18 15 17 18 15 n.d. 15 17 15 18 
Etoricoxib 1.0 n.d. 1.0 n.d. n.d. 6.0 n.d. 1.0 1.0 1.0 1.0 1.0 n.d. 2.0 1.0 1.0 1.0 1.0 1.0 
Flufenamic Acid 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 3.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 
Furosemide 10 9.0 9.0 12 14 22 12 22 9.0 13 15 48 10 9.0 9.0 9.0 9.0 9.0 10.0 
Ibuprofen 47 13 10 x 10 1 24 22 30 35 70 22 7.0 23 29 63 n.d. 38 8.0 n.d. 28 4.0 
Indomethacin n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Lorazepam n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Metformin 4.0 2.0 1.0 1.0 5.0 3.0 1.0 4.0 1.0 2.0 2.0 1.0 2.0 1.0 1.0 1.0 2.0 1.0 1.0 
Methylparaben n.d. 13 13 n.d. 14 n.d. 13 n.d. 17 18 18 18 19 n.d. 13 n.d. 14 14 n.d. 
Naproxen n.d. n.d. n.d. 2.0 n.d. n.d. n.d. 31 5.0 n.d. 8.0 n.d. n.d. 2.0 4.0 7.0 7.0 10.0 n.d. 
Omeprazole n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Paracetamol n.d. 6.0 n.d. 2.0 2.0 1.0 n.d. n.d. 33 n.d. 1.0 n.d. n.d. 2.0 n.d. 6.0 6.0 3.0 n.d. 
Propylparaben 4.0 2.0 n.d. 2.0 n.d. n.d. 2.0 4.0 n.d. 2.0 9.0 9.0 9.0 9.0 12 9.0 9.0 9.0 9.0 
Salicylic Acid 21 18 25 32 28 24 23 23 19 23 18 23 19 19 16 15 18 21 27 
Simvastatin 8.0 21 21 13 n.d. 29 12 n.d. n.d. 17 n.d. 12 n.d. n.d. n.d. 18 n.d. n.d. 4.0 
Thiamphenicol 12 n.d. 11 9.0 10 9.0 11 11 12 14 n.d. 1.0 n.d. n.d. n.d. n.d. n.d. 1.0 n.d. 
Tramadol n.d. n.d. 1.0 n.d. 1.0 2.0 2.0 2.0 n.d. 13 2.0 n.d. n.d. n.d. n.d. n.d. n.d. 1.0 1.0 
Triclocarban n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 7 9 15 n.d. 8.0 10 5.0 5.0 12 
Triclosan 10 14 8.0 7.0 8.0 8.0 13 18 9.0 17 8.0 9.0 8.0 8.0 8.0 8.0 9.0 8.0 8.0 
Warfarin 8.0 9.0 9.0 9.0 9.0 9.0 9.0 9.0 9.0 9.0 9.0 9.0 8.0 8.0 8.0 8.0 9.0 8.0 8.0 













































Concentration of PPCPs (ng g −1 ) in soil samples (So.n °) of the Albufera Natural Park, Valencia, Spain. 
Compound So.1 So.2 So.3 So.4 So.5 So.6 So.7 So.8 So.9 So.10 So.11 So.12 So.13 So.14 So.15 So.16 So.17 So.20 So.23 So.24 So.25 So.26 So.29 So.30 So.31 So.32 So.33 So.34 So.35 So.41 So.42 So.43 So.44 
Alprazolam n.d. ∗ 67 n.d. 67 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Atenolol n.d. n.d. n.d. n.d. n.d. n.d. n.d. 2.0 1.0 n.d. 21 1.0 21 n.d. 1.0 21 n.d. 1.0 21 1.0 n.d. n.d. 1.0 n.d. n.d. n.d. n.d. 21 n.d. n.d. n.d. n.d. 1.0 
Atorvastatin n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Bezafibrate n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Bisphenol A 9.0 6.0 3.0 9.0 10 4.0 8.0 4.0 7.0 6.0 10 4.0 3.0 4.0 2.0 3.0 2.0 3.0 1.0 2.0 2.0 7.0 2.0 9.0 4.0 n.d. 3.0 15 8.0 9.0 11 7.0 9.0 
Butylparaben n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Caffeine n.d. 22 24 4.0 1.0 24 n.d. 3.0 24 n.d. 22 3.0 2.0 23 1.0 22 1.0 22 3.0 1.0 26 23 23 n.d. 23 1.0 23 3.0 22 16 13 n.d. 2.0 
Chloramphenicol 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Clofibric Acid n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Codeine n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 7.0 n.d. n.d. n.d. n.d. n.d. 7.0 
Diclofenac 2.0 3.0 1.0 1.0 n.d. 1.0 1.0 2.0 1.0 n.d. n.d. n.d. n.d. n.d. n.d. 2.0 n.d. 2.0 n.d. n.d. n.d. n.d. n.d. n.d. 3.0 n.d. 2.0 2.0 n.d. n.d. 2.0 1.0 n.d. 
Enalapril n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Ethylparaben 3.0 n.d. n.d. n.d. 2.0 n.d. n.d. 3.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 3.0 n.d. n.d. 2.0 n.d. n.d. n.d. n.d. n.d. 3.0 n.d. 
Etoricoxib n.d. n.d. n.d. 1.0 n.d. n.d. 51 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Flufenamic Acid 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Furosemide n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Ibuprofen 2.0 4.0 10 n.d. 7.0 4.0 3.0 n.d. 3.0 n.d. n.d. n.d. 3.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 7.0 n.d. n.d. n.d. n.d. 8.0 n.d. 4.0 n.d. 76 3.0 n.d. 
Indomethacin n.d. n.d. n.d. n.d. n.d. 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Lorazepam n.d. n.d. 62 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 62 n.d. n.d. 62 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Metformin n.d. n.d. n.d. 47 47 n.d. 1.0 n.d. n.d. n.d. n.d. 47 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 48 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 47 n.d. 
Methylparaben n.d. 3.0 2.0 2.0 2.0 3.0 3.0 2.0 2.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.0 n.d. n.d. 2.0 n.d. n.d. 2.0 2.0 2.0 n.d. n.d. 
Naproxen 1.0 n.d. n.d. n.d. n.d. 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.0 n.d. n.d. n.d. 1.0 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.0 n.d. n.d. 
Omeprazole n.d. n.d. n.d. 2.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.0 n.d. 4.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 3.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Paracetamol n.d. n.d. 30 n.d. n.d. 1.0 n.d. n.d. 30 n.d. n.d. n.d. n.d. n.d. n.d. 30 30 31 n.d. n.d. 30 n.d. n.d. n.d. n.d. 30 n.d. n.d. 31 n.d. n.d. n.d. n.d. 
Propylparaben n.d. n.d. n.d. n.d. n.d. n.d. 2.0 n.d. 2.0 n.d. n.d. 1.0 n.d. n.d. 1.0 1.0 n.d. n.d. n.d. 3.0 n.d. 21 22 n.d. 3.0 n.d. n.d. 3.0 2.0 2.0 11 4.0 n.d. 
Salicylic Acid 9.0 n.d. n.d. n.d. 2.0 n.d. n.d. n.d. 3.0 n.d. 2.0 2.0 20 2.0 6.0 n.d. 5.0 n.d. 2.0 1.0 n.d. n.d. n.d. 3.0 n.d. n.d. n.d. 6.0 18 n.d. n.d. n.d. 5.0 
Simvastatin n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.0 n.d. n.d. n.d. n.d. 
Thiamphenicol n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 3.0 
Tramadol n.d. n.d. n.d. 2.0 n.d. 1.0 60 n.d. 60 n.d. n.d. n.d. n.d. n.d. 60 n.d. 60 n.d. n.d. n.d. n.d. n.d. n.d. 60 n.d. 1.0 n.d. n.d. n.d. n.d. 60 n.d. 60 
Triclocarban 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 2.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Triclosan 4.0 3.0 n.d. n.d. n.d. 1.0 n.d. n.d. 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.0 n.d. n.d. 1.0 n.d. 1.0 n.d. n.d. n.d. n.d. n.d. 5.0 n.d. n.d. n.d. 
Warfarin 1.0 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 














































Statistical correlations between the studied pharmaceuticals in soils ( ∗∗ Significant correlation at level of P = 0.01. ∗ Significant correlation at level of P = 0.05). 


















Nap .437 ∗ .506 ∗∗
OPZ 






TCBN .382 ∗ .420 ∗
TCSN .419 ∗ .436 ∗ .482 ∗∗
War .646 ∗∗ .940 ∗∗ .446 ∗∗ .878 ∗∗ .429 ∗ .369 ∗
Aten : Atenolol. Atorv : Atorvastatin. BZF : Bezafibrate. BisA : Bisphenol A. BPN : Butylparaben. Caf : Caffeine. CPL : Chloramphenicol. ClorA : Clofibric Acid. Cod : Codeine. DFC : Diclofenac. 
Eto r: Etoricoxib. EPB : Ethylparaben. FlufA : Flufenamic Acid. Ibup : Ibuprofen. IMTN : Indomethacin. LZM : Lorazepam. Met : Metformin. MPN : Methylparaben. Nap : Naproxen. OPZ : 













































Statistical correlations between pharmaceuticals in sediments ( ∗∗ Significant correlation at level of P = 0.01, ∗ Significant correlation at level of P = 0.05). 





BisA −.363 ∗ .363 ∗
BPN .371 ∗
Caf .522 ∗∗ .375 ∗
CPL 
ClorA 
Cod .459 ∗∗ .750 ∗∗
DFC .365 ∗ .385 ∗ −.337 ∗
Etor .349 ∗ −.516 ∗∗ −.366 ∗
EPB .347 ∗ .402 ∗ .329 ∗
FlufA .453 ∗∗
Furo .334 ∗ .334 ∗ −.401 ∗ .408 ∗
Ibup 
Met −.416 ∗∗ .363 ∗
MPN .465 ∗∗ −.332 ∗ .370 ∗ .330 ∗
OPZ .375 ∗ .376 ∗
Pmol −.458 ∗∗
PPN .469 ∗∗ .638 ∗∗ −.329 ∗
SalA .325 ∗ .572 ∗∗ −.561 ∗∗ .515 ∗∗ −.497 ∗∗
SVTN .373 ∗ .341 ∗ −.456 ∗∗ .393 ∗ −.504 ∗∗
TPL −.497 ∗∗ −.652 ∗∗ −.354 ∗ −.330 ∗ .362 ∗ .454 ∗∗ −.821 ∗∗ .468 ∗∗
Tram .461 ∗∗ −.357 ∗ .830 ∗∗ .428 ∗∗
TCSN .482 ∗∗ .374 ∗ .327 ∗ .644 ∗∗ .350 ∗ .453 ∗∗ .614 ∗∗ −.409 ∗
War −.377 ∗ .395 ∗ −.425 ∗∗ .427 ∗∗ .452 ∗∗ .339 ∗ .545 ∗∗ −.581 ∗∗ .492 ∗∗ −.581 ∗∗ .497 ∗∗
Alpraz : Alprazolam. Aten : Atenolol. Atorv : Atorvastatin. BZF : Bezafibrate. BisA : Bisphenol A. BPN : Butylparaben. Caf : Caffeine. CPL : Chloramphenicol. Clor A : Clofibric Acid. Cod : 
Codeine. DFC : Diclofenac. Etor : Etoricoxib. EPB : Ethylparaben. Fluf A : Flufenamic Acid. Furo : Furosemide. Ibup : Ibuprofen. Met: Metformin. MPN : Methylparaben. OPZ : Omeprazole. 














































Statistical correlations between the studied pharmaceuticals in waters ( ∗∗ Significant correlation at level of P = 0.01, ∗ Significant correlation at level of P = 0.05). 
Alpraz Aten Atorv BZF BisA BPN Caf CPL ClorA Cod DFC Etor EPB FlufA Furo Ibup IMTN LZM Met MPN Nap Pmol PPN TPL Tram 
Aten .830 ∗∗
Atorv 
BZF .858 ∗∗ .899 ∗∗




Cod .871 ∗∗ .929 ∗∗ .830 ∗∗ .423 ∗ .358 ∗
DFC .584 ∗∗ .598 ∗∗ .442 ∗∗ .550 ∗∗
Etor .469 ∗∗ .410 ∗ .410 ∗ .532 ∗∗ .538 ∗∗ .472 ∗∗
FlufA .908 ∗∗ .773 ∗∗ .745 ∗∗ .454 ∗∗ .503 ∗∗ .828 ∗∗ .530 ∗∗ .416 ∗
Ibup .422 ∗ .498 ∗∗ .372 ∗ .393 ∗ .368 ∗
IMTN .356 ∗ .521 ∗∗ .589 ∗∗ .421 ∗ .450 ∗∗ .510 ∗∗
LZM .870 ∗∗ .956 ∗∗ .848 ∗∗ .380 ∗ .935 ∗∗ .624 ∗∗ .445 ∗∗ .803 ∗∗ .456 ∗∗
Met .477 ∗∗ .439 ∗ .476 ∗∗ .461 ∗∗
MPN .376 ∗ .377 ∗
Nap .462 ∗∗ .609 ∗∗ .463 ∗∗ .528 ∗∗ .593 ∗∗ .401 ∗ .550 ∗∗ .370 ∗ .395 ∗ .466 ∗∗ .586 ∗∗ .435 ∗
Pmol .874 ∗∗ .345 ∗
PPN .427 ∗ .554 ∗∗ −.418 ∗
SalA .354 ∗ .513 ∗∗ .572 ∗∗
TPL .406 ∗ .475 ∗∗ .372 ∗ .510 ∗∗ .377 ∗ .475 ∗∗
Tram .951 ∗∗ .890 ∗∗ .808 ∗∗ .401 ∗ .371 ∗ .953 ∗∗ .641 ∗∗ .514 ∗∗ .899 ∗∗ .534 ∗∗ .924 ∗∗ .423 ∗ .546 ∗∗ .494 ∗∗
TCBN .435 ∗ .535 ∗∗ .480 ∗∗
TCSN .387 ∗
War .412 ∗ .386 ∗ .374 ∗ .448 ∗∗ .401 ∗ .362 ∗ .473 ∗∗ .570 ∗∗ .364 ∗ .419 ∗
Aten : Atenolol. Alpraz : Alprazolam. Atorv : Atorvastatin. BZF : Bezafibrate. BisA : Bisphenol A. BPN : Butylparaben. CPL : Chloramphenicol. ClorA : Clofibric Acid. Cod : Codeine. DFC : 
Diclofenac. Etor : Etoricoxib. FlufA : Flufenamic Acid. Ibup : Ibuprofen. IMTN : Indomethacin. LZM : Lorazepam. Met : Metformin. MPN : Methylparaben. Nap : Naproxen. Pmol : Paracetamol. 
PPN : Propylparaben. SalA : Salicylic acid. TPL : Thiamphenicol. Tram : Tramadol. TCBN : Triclocarban. TCSN : Triclosan. War : Warfarin. 
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Table 10 
Statistical correlations between pharmaceuticals and intrinsic soil characteristics ( ∗∗ Significant correlation at level of 
P = 0.01. ∗ Significant correlation at level of P = 0.05). 
pH EC CO 3 OM Na K Mg Ca CEC 
Alpraz −.380 ∗ .410 ∗ .451 ∗∗
BisA .358 ∗ .421 ∗ .372 ∗
Ibup .353 ∗
MPN −.376 ∗ .4 4 4 ∗∗
Nap −.364 ∗
PPN −.352 ∗
TPL .354 ∗ .446 ∗∗
TCSN .359 ∗
War .396 ∗ .414 ∗
EC : Electric conductivity. CO 3 
= : Carbonates. OM : Organic Matter. Na: Sodium. K: Potasium. Mg: Magnesium. Ca: Calcium. 
CEC : Cation Exchange Capacity. 
Alpraz : Alprazolam. BisA : Bisphenol A. Ibup : Ibuprofen. MPN : Methylparaben. Nap : Naproxen. PPN : Propylparaben. TPL : 
Thiamphenicol. TCSN : Triclosan. War : Warfarin. 
Table 11 
Statistical correlations between pharmaceuticals and intrinsic sediment characteristics ( ∗∗ Significant correlation at level 
of P = 0.01, ∗ Significant correlation at level of P = 0.05). 
OM CO 3 







Caf −.484 ∗∗ .555 ∗∗ −.325 ∗
CPL 





FlufA .378 ∗ −.398 ∗
Furo −.382 ∗
Ibup −.334 ∗ −.366 ∗ .345 ∗ −.335 ∗
Met 
MPN .426 ∗∗ −.579 ∗∗ −.399 ∗
OPZ −.344 ∗
Pmol .348 ∗
PPN .512 ∗∗ .477 ∗∗ .565 ∗∗ −.490 ∗∗ .510 ∗∗ .368 ∗
SalA −.501 ∗∗ −.614 ∗∗ −.612 ∗∗ .582 ∗∗
SVTN −.345 ∗ −.328 ∗
TPL −.586 ∗∗ −.470 ∗∗ .406 ∗ −.401 ∗
Tram 
TCSN 
War −.402 ∗ −.407 ∗
OM : Organic Matter. CO 3 
= : Carbonates. Sac : Lime + clay fractions. SandT : Total sand fraction. EC : Electric conductivity. 
CEC : Cation Exchange Capacity. 
Alpraz : Alprazolam. Aten : Atenolol. Atorv : Atorvastatin. BZF : Bezafibrate. BisA : Bisphenol A. BPN : Butylparaben. Caf : 
Caffeine. CPL : Chloram phenicol. Clor A : Clofibric Acid. Cod : Codeine. DFC : Diclofenac. Etor : Etoricoxib. EPB : Ethyl- 
paraben. Fluf A : Flufenamic Acid. Furo : Furosemide. Ibup : Ibuprofen. Met : Metformin. MPN : Methylparaben. OPZ : 
Omeprazole. Pmol : Paracetamol. PPN : Propylparaben. SalA : Salicylic acid. SVTN : Simvastatin. TPL : Thiamphenicol. Tram : 
Tramadol. TCSN : Triclosan. War : Warfarin. 
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Table 12 
Statistical correlations between the studied pharmaceuticals and intrinsic characteristics of waters ( ∗∗ Significant corre- 
lation at level of P = 0.01, ∗ Significant correlation at level of P = 0.05). 





Caf −.410 ∗ −.365 ∗ −.388 ∗ −.385 ∗









Nap .359 ∗ .387 ∗ −.480 ∗∗
Pmol −.354 ∗ −.356 ∗
SalA −.402 ∗ −.387 ∗ −.373 ∗
TPL −.420 ∗ .364 ∗ .736 ∗∗
Tram −.491 ∗∗
TCBN .440 ∗ −.355 ∗
T : temperature ( °C). EC : Electric Conductivity (dS/m). TDS : Total Dissolved Solids (mg/L). Rest : Resistivity ( Ώ). DO% : 
Dissolved Oxygen (%). Cl −: Chlorides (mg/L). NO 2 −: Nitrites. NO 3 = : Nitrates (mg/L). SO 4 = : Sulfates (mg/L). Alpraz : Al- 
prazolam. Aten : Atenolol. Atorv : Atorvastatin. Caf : Caffeine. ClorA : Clofibric Acid. Cod : Codeine. EPB : Ethylparaben. Fl- 
ufA : Flufenamic Acid. Furo : Furosemide. IMTN : Indomethacin. LZM : Lorazepam. Met : Metformin. Nap : Naproxen. Pmol : 



























A  nvironmental compartments. A previous solid-liquid extraction was performed for solid sam-
les (1g), with the use of 15 mL of a mix containing Milli-Q water, McIlvaine–EDTA buffer and
ethanol (MeOH) in equal parts. The mixture was homogenized for 5 min by vortex agitation,
onicated for 10 min, and centrifuged for 6 min at 30 0 0 rpm and 10 °C. The supernatant was
eparated and diluted with Milli-Q water to 200 mL. Then, the dilution was treated such as
ater extraction procedure. 
The clean-up that involves PPCPs isolation and concentration were performed by Solid Phase
xtraction (SPE). Two methods employing different cartridges Strata-X and Strata-X-CW (Phe-
omenex, 33 μm, 200 mg/6 mL) characterized by a polymeric reversed and polymeric weak cation-
xchange stationary phase, respectively, were used. Strata-X was activated with 6 mL MeOH, 6
L Milli-Q water and with 6 mL 2mM Sodium Dodecyl Sulphate (SDS) solution ( SDS method ).
hile, Strata-X-CW was activated without SDS solution ( WC method ). The analytes were eluted
ith 6mL of MeOH and 3 mL of MeOH–DCM (50:50 v/v) for reversed phase and with 6 mL of
eOH–NH 4 OH (95:5 v/v) for weak cation-exchange phase by gravity. The eluates were evapo-
ated at 40 °C and redissolved to 1 mL with mobile phase before injection. 
Alprazolam, atorvastatin, caffeine, chloramphenicol, diclofenac, flufenamic acid, furosemide,
buprofen, omeprazole, paracetamol and thiamphenicol were detected by WC method in water,
ediment and soil matrix. While, atenolol, bezafibrate, butylparaben, clorfibric acid, enalapril,
thylparaben, etoricoxib, indomethacin, lorazepam, metformin, methylparaben, naproxen, propy-
paraben, salicylic acid, simvastatin tramadol, triclocarban, triclosan, warfarin by SDS method .
nly bisphenol A and codeine were determined by both methods, SDS in water matrix and WC
n sediment and soil. 
Instrumental analysis was performed by 1260 Infinity UHPLC (ultra-high-performance liquid
hromatography) system coupled to mass spectrometry with a triple quadrupole mass detec-
or (6410 QqQ-MS) from Agilent Technologies (Santa Clara, CA, USA). The electrospray ionization
ESI) was applied in negative and positive mode. The mobile phase consisted of MeOH (solvent
) and water (solvent B) both with NH 4 F at 2.5 mmol L 
−1 for negative mode and MeOH (sol-






























vent A) and water (solvent B) with 0.1% formic acid in both solutions for positive mode. The
calibration curves used to quantify the environmental contaminants were prepared in H 2 O-
MeOH (70-30) and in solvent with SDS to obtain correct quantification of those compounds. 
The qualitative and quantitative analysis of each chromatogram were performed by
MassHunter Workstation (version 10.0 Software) supplied by Agilent Technologies. The statis-
tical relationship of the different contaminants between them and with the environmental pa-
rameters in the three matrices selected (water, soil and sediment) was carried out by Statistical
package IBM SPSS (version 26.0). 
The limits of detection (LODs) and limits of quantification (LOQs) were estimated experimen-
tally, spiking blank samples, at the lowest concentration (10 ng g −1 and 50 μgL −1 ), with the
PPCPs pre-extraction and estimating the analyte concentration able to provide a signal-to-noise
ratio of 3 and 10 respectively. The LODs ranged from 1.65 and 16.65 ngL −1 in waste and surface
water, and from 0.33 and 6.67 ng g −1 dry weight (d.w.) in sediment and soil. Particularly, to
established the matrix effects (ME) two eight point calibration curves (10, 25, 50, 75, 100, 250,
50 0, 10 0 0 ng/mL) were compared: (i) one prepared in solvent (that is H 2 O-MeOH (70-30) or
this mixture with SDS depending on the method) and (ii) the other prepared in blank matrix
extract, also redissolving the extract in H 2 O-MeOH (70-30) or this mixture with SDS. Then, the
ME was calculated according to the formula: 
ME (%) = 
(
Slope of calibration curv e in matrix 
Slope of calibration curv e in solution 
− 1 
)
× 100 (1) 
This information together with other experimental information were described in the Sadutto
[2] work. 
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